TheEdgeResearch
Home / Stocks / BCYP

Big Cypress Acquisition Corp. (BCYP)

NASDAQ Healthcare Biotechnology
$8.44 ▼ -19.23%
Market Cap
$425.4M
Sector
Healthcare
Industry
Biotechnology
Beta
0.00
52-Wk Range
8.23-12.8985
CEO
Samuel J. Reich
Country
US
Currency
USD

Big Cypress Acquisition Corp. operates in the Biotechnology industry of the Healthcare sector, headquartered in Miami Beach, FL, US. The stock last traded at $8.44, down 19.23% on the session, giving a market capitalisation of $425.4M. On trailing twelve-month figures it carries a trailing P/E of -8.44, a net margin of 0.0%. Its beta of 0.00 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-8.44
Price / Sales
0.00
Price / Book
3.13
EV / EBITDA
-73.61
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
0.02
Current ratio
9.22
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Select
Employees
IPO date
2021-02-09
Headquarters
Miami Beach, FL, US
About Big Cypress Acquisition Corp.

Big Cypress Acquisition Corp. (BCYP) aims to acquire businesses and assets. This is accomplished through various strategies, including mergers, stock purchases, capital stock exchanges, reorganizations, or comparable business integrations. The company specifically targets life science enterprises situated within the United States and Israel. It was established in 2020 and operates from its headquarters in Miami Beach, Florida.

Comparable companies

Big Cypress Acquisition Corp. is most often compared with the following Healthcare names:

CKPTCLYMGTHXITOSIVVDORTXRVNCSVAVIGLYMAB
More research on BCYP
BCYP technical analysis BCYP TheEdge Score Compare against peers
Open full interactive analysis & DCF →